← Evidence map

TrialThe Journal of clinical investigation2014

RASAL2 activates RAC1 to promote triple-negative breast cancer progression.

Min Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

62 papers cite itlatest 60 shown

2014
…
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25384218